Logo

Clinical Chemistry

News on clinical chemistry systems and applications.

Abbott Focusing on Base Business Recovery, but COVID-19 Testing Remains Crucial Revenue Source
Premium

The company is working to expand the test menus on its instruments and capitalizing on new placements to gain further market share.

Quidel to Acquire Ortho Clinical Diagnostics for $6B

The firms expect the deal will lead to cost synergies of $90 million by end of year three, and revenue synergies greater than $100 million by 2025.

Abbott Q3 Diagnostics Revenues Rise 48 Percent on Core Lab, Rapid Diagnostics Sales Growth

The firm said its global COVID-19 testing-related sales were $1.9 billion in the third quarter, while its Rapid Diagnostics revenues rose 145 percent year over year.

Ochsner Health Integrating ActX Genomic Decision Support to Pilot Cancer PGx Project

The ActX platform will allow physicians to check drug-gene interactions in real time in the EHR workflow against the therapies cancer patients are prescribed.

Baebies Awarded up to $11.6M in CARB-X Funding for Neonatal Sepsis Test

The rapid, point-of-care test is being developed to run on the Durham, North Carolina-based company's Finder digital microfluidics instrument.

Oct 14, 2020

PerkinElmer to Provide Testing for BioMarin Program in Mexico

Aug 5, 2020

NeuMoDx Molecular Receives CE Mark for Quantitative BK Viral Assay

Mar 25, 2020

Sentinel Diagnostics Looks to Expand Global Influence With SARS-CoV-2 Test

Dec 6, 2019

Local Coverage Determinations Roundup: Transplant Genomics, Opko Health

Jul 17, 2019

Abbott Q2 Diagnostics Revenues Rise 2 Percent, MDx Revenues Down 12 Percent

Apr 17, 2019

Abbott Q1 Diagnostics Revenues Flat

Jan 17, 2019

BD Preliminary Fiscal Q1 Revenues Up 35 Percent on Continued Bard Boost

Nov 8, 2018

Meridian Bioscience Q4 Revenues Grow 7 Percent

Oct 17, 2018

Abbott Q3 Dx Business Grows 43 Percent

Jul 31, 2018

Meridian Bioscience Q3 Revenues Grow 3 Percent

Jul 18, 2018

Abbott Q2 Organic Dx Revenues Rise 7 Percent Driven by Core Lab, MDx Sales

May 14, 2018

Siemens Healthineers Eyes New Opportunities for Molecular Segment as Dx Business Coalesces Post-IPO

Apr 26, 2018

Roche Q1 Diagnostics Revenues Rise 5 Percent, Liat Sales Surge

Feb 23, 2018

Studies Suggest Challenges Remain for Dried Blood Spot Protein Assays
Premium

Feb 15, 2018

Dutch Researchers Develop Mass Spec Test for Multiple Myeloma
Premium

Feb 14, 2018

Industry Pros Suggest Proteomic Dx Technology Ready for Routine Application
Premium

Feb 1, 2018

Roche Diagnostics 2017 Revenues Rise 5 Percent Boosted by Immunodiagnostics, Tissue Dx Growth

Jan 30, 2018

Life Sciences, Diagnostics Drive Danaher Q4 Revenues Up 11 Percent

Nov 2, 2017

Bio-Rad Q3 Revenues Grow 5 Percent

Oct 9, 2017

Novilytic Using $1.5M SBIR Grant to Develop Immunoenrichment Tech for Clinical Mass Spec
Premium

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.